Halleridone

Details

Top
Internal ID 6c0e0a61-d72e-4103-a86d-d1eded424b39
Taxonomy Organoheterocyclic compounds > Benzofurans
IUPAC Name 3a-hydroxy-2,3,7,7a-tetrahydro-1-benzofuran-6-one
SMILES (Canonical) C1COC2C1(C=CC(=O)C2)O
SMILES (Isomeric) C1COC2C1(C=CC(=O)C2)O
InChI InChI=1S/C8H10O3/c9-6-1-2-8(10)3-4-11-7(8)5-6/h1-2,7,10H,3-5H2
InChI Key HSGPAWIMHOPPDA-UHFFFAOYSA-N
Popularity 5 references in papers

Physical and Chemical Properties

Top
Molecular Formula C8H10O3
Molecular Weight 154.16 g/mol
Exact Mass 154.062994177 g/mol
Topological Polar Surface Area (TPSA) 46.50 Ų
XlogP -0.70
Atomic LogP (AlogP) 0.04
H-Bond Acceptor 3
H-Bond Donor 1
Rotatable Bonds 0

Synonyms

Top
orb2283378
SCHEMBL10523903
DTXSID10915459
AKOS032948562
FS-7312
3a-hydroxy-3,3a,7,7a-tetrahydro-1-benzofuran-6(2H)-one
6(2H)-Benzofuranone, 3,3a,7,7a-tetrahydro-3a-hydroxy-
B0005-172240

2D Structure

Top
2D Structure of Halleridone

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9961 99.61%
Caco-2 + 0.6611 66.11%
Blood Brain Barrier + 0.5750 57.50%
Human oral bioavailability + 0.6571 65.71%
Subcellular localzation Mitochondria 0.7446 74.46%
OATP2B1 inhibitior - 0.8553 85.53%
OATP1B1 inhibitior + 0.9552 95.52%
OATP1B3 inhibitior + 0.9655 96.55%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.6750 67.50%
BSEP inhibitior - 0.9674 96.74%
P-glycoprotein inhibitior - 0.9775 97.75%
P-glycoprotein substrate - 0.9284 92.84%
CYP3A4 substrate - 0.5285 52.85%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8352 83.52%
CYP3A4 inhibition - 0.9733 97.33%
CYP2C9 inhibition - 0.9047 90.47%
CYP2C19 inhibition - 0.8008 80.08%
CYP2D6 inhibition - 0.9490 94.90%
CYP1A2 inhibition - 0.8558 85.58%
CYP2C8 inhibition - 0.9695 96.95%
CYP inhibitory promiscuity - 0.9654 96.54%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.9800 98.00%
Carcinogenicity (trinary) Non-required 0.5272 52.72%
Eye corrosion - 0.8909 89.09%
Eye irritation + 0.9278 92.78%
Skin irritation - 0.7251 72.51%
Skin corrosion - 0.9351 93.51%
Ames mutagenesis - 0.5300 53.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7644 76.44%
Micronuclear - 0.9100 91.00%
Hepatotoxicity + 0.6704 67.04%
skin sensitisation - 0.8240 82.40%
Respiratory toxicity + 0.5667 56.67%
Reproductive toxicity + 0.5778 57.78%
Mitochondrial toxicity + 0.5500 55.00%
Nephrotoxicity + 0.5513 55.13%
Acute Oral Toxicity (c) III 0.6250 62.50%
Estrogen receptor binding - 0.7168 71.68%
Androgen receptor binding - 0.7980 79.80%
Thyroid receptor binding - 0.8489 84.89%
Glucocorticoid receptor binding - 0.7255 72.55%
Aromatase binding - 0.8581 85.81%
PPAR gamma - 0.7000 70.00%
Honey bee toxicity - 0.9258 92.58%
Biodegradation - 0.5500 55.00%
Crustacea aquatic toxicity - 0.5000 50.00%
Fish aquatic toxicity - 0.5946 59.46%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 95.16% 91.11%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 87.23% 94.45%
CHEMBL3137262 O60341 LSD1/CoREST complex 85.91% 97.09%
CHEMBL2553 Q15418 Ribosomal protein S6 kinase alpha 1 84.12% 85.11%
CHEMBL1994 P08235 Mineralocorticoid receptor 83.45% 100.00%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 83.26% 95.56%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 82.83% 90.71%
CHEMBL1806 P11388 DNA topoisomerase II alpha 81.68% 89.00%

Plants that contains it

Top

Cross-Links

Top
PubChem 146831
LOTUS LTS0161953
wikiData Q82886463